These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16904179)

  • 1. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.
    Reglödi D; Lubics A; Kiss P; Lengvári I; Gaszner B; Tóth G; Hegyi O; Tamás A
    Neuropeptides; 2006 Aug; 40(4):265-74. PubMed ID: 16904179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
    Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
    Reglodi D; Tamás A; Lubics A; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):85-94. PubMed ID: 15518897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.
    Reglódi D; Tamás A; Lengvári I; Toth G; Szalontay L; Lubics A
    Ann N Y Acad Sci; 2006 Jul; 1070():518-24. PubMed ID: 16888218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
    Tamás A; Lubics A; Szalontay L; Lengvári I; Reglodi D
    Behav Brain Res; 2005 Mar; 158(2):221-9. PubMed ID: 15698888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.
    Maasz G; Zrinyi Z; Reglodi D; Petrovics D; Rivnyak A; Kiss T; Jungling A; Tamas A; Pirger Z
    Dis Model Mech; 2017 Feb; 10(2):127-139. PubMed ID: 28067625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.
    Debeir T; Ginestet L; François C; Laurens S; Martel JC; Chopin P; Marien M; Colpaert F; Raisman-Vozari R
    Exp Neurol; 2005 Jun; 193(2):444-54. PubMed ID: 15869947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
    Falk T; Zhang S; Sherman SJ
    Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.
    Li LY; Zhao XL; Fei XF; Gu ZL; Qin ZH; Liang ZQ
    Acta Pharmacol Sin; 2008 May; 29(5):539-47. PubMed ID: 18430361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
    Mu X; He G; Cheng Y; Li X; Xu B; Du G
    Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
    Singh S; Ahmad R; Mathur D; Sagar RK; Krishana B
    Indian J Exp Biol; 2006 Sep; 44(9):699-704. PubMed ID: 16999024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
    Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
    Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
    Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
    Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in PACAP levels in the central nervous system after ovariectomy and castration.
    Nemeth J; Tamas A; Jozsa R; Horvath JE; Jakab B; Lengvari I; Arimura A; Lubics A; Reglódi D
    Ann N Y Acad Sci; 2006 Jul; 1070():468-73. PubMed ID: 16888211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.
    Huang HY; Lin SZ; Kuo JS; Chen WF; Wang MJ
    Neurobiol Aging; 2007 Aug; 28(8):1258-69. PubMed ID: 16839644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
    Steiner B; Winter C; Hosman K; Siebert E; Kempermann G; Petrus DS; Kupsch A
    Exp Neurol; 2006 Jun; 199(2):291-300. PubMed ID: 16360152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.